Evidence map›Paper›PMID 30177609›Full record

ArticleInternational journal of molecular sciences2018

Gosha-Jinki-Gan Recovers Spermatogenesis in Mice with Busulfan-Induced Aspermatogenesis.

Ning Qu, Miyuki Kuramasu, Yoshie Hirayanagi, Kenta Nagahori, Shogo Hayashi, Yuki Ogawa, Hayato Terayama, Kaori Suyama, Munekazu Naito, Kou Sakabe and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Ning QuDepartment of Anatomy, Division of Basic Medical Science, Tokai University School of Medicine, Kanagawa 259-1193, Japan. quning@tokai.ac.jp.ORCID 0000-0001-5110-6719
Miyuki KuramasuDepartment of Anatomy, Tokyo Medical University, Tokyo 160-8402, Japan. kitaoka@tokyo-med.ac.jp.
Yoshie HirayanagiDepartment of Anatomy, Tokyo Medical University, Tokyo 160-8402, Japan. anatomy@tokyo-med.ac.jp.
Kenta NagahoriDepartment of Anatomy, Tokyo Medical University, Tokyo 160-8402, Japan. kenta-n@tokyo-med.ac.jp.
Shogo HayashiDepartment of Anatomy, Tokyo Medical University, Tokyo 160-8402, Japan. sho5-884@umin.ac.jp.ORCID 0000-0003-0302-7658
Yuki OgawaDepartment of Anatomy, Tokyo Medical University, Tokyo 160-8402, Japan. yogawa@tokyo-med.ac.jp.
Hayato TerayamaDepartment of Anatomy, Division of Basic Medical Science, Tokai University School of Medicine, Kanagawa 259-1193, Japan. terahaya@tokai-u.jp.
Kaori SuyamaDepartment of Anatomy, Division of Basic Medical Science, Tokai University School of Medicine, Kanagawa 259-1193, Japan. suyama@is.icc.u-tokai.ac.jp.
Munekazu NaitoDepartment of Anatomy, Aichi Medical University, 1-1 Yazakokarimata, Nagakute, Aichi 480-1195, Japan. munekazunaito@gmail.com.ORCID 0000-0003-0618-0607
Kou SakabeDepartment of Anatomy, Division of Basic Medical Science, Tokai University School of Medicine, Kanagawa 259-1193, Japan. sakabek@tokai-u.jp.
Masahiro ItohDepartment of Anatomy, Tokyo Medical University, Tokyo 160-8402, Japan. itomasa@tokyo-med.ac.jp.
Tokyo Medical University · JPTokai University · JPAichi Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Busulfan is an anti-cancer chemotherapeutic drug and is often used as conditioning regimens prior to bone marrow transplant for treatment of chronic myelogenous leukemia. Male infertility, including spermatogenesis disturbance, is known to be one of the side effects of anticancer drugs. While hormone preparations and vitamin preparations are used for spermatogenesis disturbance, their therapeutic effects are low. Some traditional herbal medicines have been administered to improve spermatogenesis. In the present study, we administered Gosha-jinki-gan (TJ107; Tsumura Co., Ltd., Tokyo, Japan) to mice suffering from severe aspermatogenesis after busulfan treatment to determine whether TJ107 can recover spermatogenesis. Male 4-week-old C57BL/6J mice were administered a single intraperitoneal injection of busulfan, and they were then fed a normal diet for 60 days and then a TJ107 diet or TJ107-free normal diet for another 60 days. After busulfan treatment, the weight of the testes and the epididymal sperm count progressively decreased in the normal diet group. On the other hand, in the TJ107 group, these variables dramatically recovered at 120 days. These results suggest that busulfan-induced aspermatogenesis is irreversible if appropriate treatment is not administered. Supplementation of TJ107 can completely recover the injured seminiferous epithelium via normalization of the macrophage migration and reduction of the expressions of Tool-like receptor (TLR) 2 and TLR4, suggesting that TJ107 has a therapeutic effect on busulfan-induced aspermatogenesis.

Indexed as

AnimalsAntineoplastic AgentsBusulfanDrugs, Chinese HerbalInjections, IntraperitonealMaleMedicine, East Asian TraditionalMiceSpermatogenesisAntineoplastic AgentsBusulfanDrugs, Chinese Herbalgosha-jinki-gananticancer treatmentaspermatogenesisoriental medicinetesticular immunology

Identifiers

PMID30177609
PMCPMC6165450
OpenAlexW2889108090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.